carbocyclic arabinosyladenine: structure
ID Source | ID |
---|---|
PubMed CID | 166765 |
MeSH ID | M0062879 |
Synonym |
---|
furo[2',3':4,5]oxazolo[3,2-e]purine-8-methanol, 4-amino-6a,7,8,9a-tetrahydro-7-hydroxy-, (6as,7r,8r,9ar)- |
carbocyclic arabinosyladenine |
cyclic arabinosyladenine |
furo(2',3':4,5)oxazolo(3,2-e)purine-8-methanol, 4-amino-6a,7,8,9a-tetrahydro-7-hydroxy-, (6as-(6aalpha,7alpha,8beta,9aalpha))- |
carbocyclic arabinofuranosyladenine |
13089-44-6 |
4-amino-8-(hydroxymethyl)-6a,7,8,9a-tetrahydrofuro[2',3':4,5][1,3]oxazolo[3,2-e]purin-7-ol |
DTXSID00926958 |
(11s,12r,13r,15r)-6-amino-13-(hydroxymethyl)-10,14-dioxa-1,3,5,8-tetrazatetracyclo[7.6.0.02,7.011,15]pentadeca-2,4,6,8-tetraen-12-ol |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.87) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |